– Dr. Yakatan has been endorsed by Marquis Who’s Who as …Continue Reading
Read more新闻发布
IRISYS Chairman, CEO & Founder Recognized as “International Cooperation Ambassador” for Life Science City in China
– Dr. Jerry Yakatan, Chairman, CEO & Founder of IRI …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Represents Biotech Industry at San Diego US-China Trade Relations Meeting
– Dr. Jerry Yakatan, Chairman, CEO & Founder of IRI …Continue Reading
Read moreIRISYS To Expand Drug Delivery Technology Capabilities & Services in China
– IRISYS Announces Joint Venture with Zhejiang Yangtze …Continue Reading
Read moreIRISYS Discussions at CPhI China feature Gerald Yakatan, Ph.D., Chairman, CEO & Founder
IRISYS to discuss its customized services for international clients at the leading pharmaceutical industry event in China…
Read moreIRISYS’ SCOT-TUSSIN Products will be Exhibited at the 2018 Cardinal Health Retail Business Conference
Louis Scotti, Division President, will Showcase the SCOT-TUSSIN Sugar-free & Alcohol-free Medicines for Diabetic/Hypertensive Consumers…
Read moreIRISYS Awarded NCATS “CRO Support for Drug Product Development, Manufacture, and Stability Studies” Contract for Up To $14.4 Million
– Contract from the National Center for Advancing Trans …Continue Reading
Read moreIRISYS Management is in High Demand at Contract Manufacturing / Packaging / Logistics for Pharmaceuticals & Nutritionals Conference
– More than 40 life sciences companies request meetings …Continue Reading
Read moreIRISYS Expertise and Asian Outreach Discussed at BIOtech Japan 2017 Conference
– IRISYS Chairman, CEO & Founder Gerald Yakatan, Ph …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., is a Featured “Innovative Thought Leader” at the 7th Clinical Trials Innovation Programme
– Dr. Yakatan to Discuss: “Where Have All the New Drugs …Continue Reading
Read moreIRISYS Exhibits at Inaugural CPhI North America Conference
– Louis Scotti, Vice President, Business Development, l …Continue Reading
Read moreIRISYS Contract with NCI for Manufacturing Clinical Trial Materials is Doubled in Value
– Award Increased to Up To $6,000,000 Over Five Years – …Continue Reading
Read moreIRISYS to be Represented at CPhI Japan by Chairman, CEO & Founder Gerald Yakatan, Ph.D.
– Dr. Yakatan will hold meetings to discuss IRISYS’ cus …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Participates in the 8th Annual Life Science CEO Forum
– Dr. Yakatan joins discussions with executives from ph …Continue Reading
Read moreIRISYS Chairman, CEO & Founder Gerald Yakatan, Ph.D., Moderates FDA Panel at The International Conference on Drug Development
– Dr. Yakatan to Direct a Discussion with FDA CDER Lead …Continue Reading
Read moreIRISYS Awarded Long Term Contract by NCI for Manufacturing Clinical Trial Materials
–Valued at Up To $3,000,000 Over Five Years – SAN DIEGO …Continue Reading
Read moreIRISYS Receives MetroConnect Award & California Competes Tax Credit
– Helps Support IRISYS Expansion Plans in San Diego and …Continue Reading
Read more